Philina Lee

Corporate Officer/Principal bei BLUEPRINT MEDICINES CORPORATION

Vermögen: 4 Mio $ am 31.05.2024

47 Jahre

Health Technology

Consumer Services

Finance

Aktive Positionen von Philina Lee

Unternehmen	Position	Beginn	Ende
BLUEPRINT MEDICINES CORPORATION	Corporate Officer/Principal	01.01.2021	-

Unternehmen	Position	Beginn	Ende
FUSN PHAR	Direktor/Vorstandsmitglied	11.02.2021	04.06.2024
FUSN PHAR	Independent Dir/Board Member	11.02.2021	04.06.2024
ALGETA ASA	Corporate Officer/Principal	-	-

University of Alberta	Undergraduate Degree
Massachusetts Institute of Technology	Doctorate Degree

International

Operativ

Corporate Officer/Principal	2
Undergraduate Degree	1
Director/Board Member	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
BLUEPRINT MEDICINES CORPORATION	Health Technology

Private Unternehmen	2
Fusion Pharmaceuticals, Inc. Fusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.	Health Technology
Algeta ASA Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway.	Health Technology

Private Unternehmen

Health Technology